logo
15:24 Dec 15

Lincoln Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
483.30
+10.45 (+2.21%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Lincoln Pharmaceuticals Ltd. Financials

Lincoln Pharmaceuticals Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
483.30
+10.45 (+2.21%)
15:24 Dec 15
Quality
image/svg+xml

55/100
High Financial Strength

Valuation
image/svg+xml

51/100
Affordable Valuation

Technical

27/100
Technically Bearish

Strength

7

Weakness

3

Opportunity

0

Threats

0

12.25 %

ROE %

10.33 %

ROA %

39.94

EPS

335.34

BVPS

13.21 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
472.12 510.31 580.55 623.23 632.16
Operating Expenses +
376.64 421.1 480.65 521.74 532.55
Raw Material
232.15 245.64 284.03 282.48 293.17
Increase Decrease in Cost
-13.57 -4.24 -5.7 8.84 1.75
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
70.47 93.16 102.9 112.45 117.72
Miscellaneous Expenses
234.93 223.82 265.24 255.05 119.91
Operating Profit
95.48 89.21 99.9 101.49 99.61
Other Income
10 22.47 34.42 22.48 24.59
Depreciation
8.09 9.17 10.62 12.9 13.55
Interest
1.45 2.03 1.46 1.88 1.54
Profit before tax and exceptio..
95.94 100.48 122.24 109.19 109.11
Exceptional Items
0 0 0 0 0
PBT
95.94 100.48 122.24 109.19 109.11
Provision for Taxation
26.58 27.58 28.94 26.84 29.12
Net Profit
69.36 72.9 93.3 82.35 80.01
NET Profit after MI
69.36 72.9 93.3 82.35 80.01
EPS
34.63 36.4 46.58 41.11 39.95
Operating Profit Margin (%)
20.22 17.48 17.21 16.28 15.76
Net Profit Margin (%)
14.69 14.29 16.07 13.21 12.66

Lincoln Pharmaceuticals Ltd. Shareholding

All Data in Percentage (%)
Promoter - - - - -
FII - - - - -
Public - - - - -
MF - - - - -
Others
Shareholder Shares Holding %
Research 360 logo
Download Our App On: